Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
SHSCX vs HRTS
Shared holdings
32
SHSCX covered by HRTS
56.53%
HRTS covered by SHSCX
56.53%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
SHSCX (Feb. 27, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.27% | |
| JOHNSON&JOHNSON | 10.15% | |
| ABBVIE INC | 4.09% | |
| GILEAD SCIENCES INC | 3.93% | |
| MERCK & CO | 3.52% | |
| AMGEN INC | 3.47% | |
| UNITEDHEALTH GRP | 3.02% | |
| INTUITIVE SURGICAL INC | 2.44% | |
| ABBOTT LABS | 2.41% | |
| DANAHER CORP | 2.29% | |
| THERMO FISHER SCIENTIFIC INC | 2.26% | |
| EDWARDS LIFESCIENCES CORP | 2.25% | |
| VERTEX PHARMACEUTICALS INC | 2.06% | |
| MEDTRONIC PLC | 1.98% | |
| STRYKER CORP | 1.96% | |
| TEVA PHARMACEUTICAL IND ADR | 1.79% | |
| CENCORA INC | 1.50% | |
| BOSTON SCIENTIFIC CORP | 1.50% | |
| ASTRAZENECA PLC | 1.44% | |
| ARGENX SE SPONSORED ADR | 1.41% | |
| MCKESSON CORP | 1.20% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 1.07% | |
| BIOGEN INC | 1.06% | |
| ALNYLAM PHARMACEUTICALS INC | 1.05% | |
| REGENERON PHARMACEUTICALS INC | 1.04% | |
| BRISTOL-MYERS SQUIBB CO | 1.04% | |
| HCA HEALTHCARE INC | 1.01% | |
| BlackRock Cash Funds: Institutional, SL Agency Shares | 0.87% | |
| EXACT SCIENCES CORP | 0.86% | |
| RHYTHM PHARMACEUTICALS INC | 0.76% | |
| IDEXX LABS INC | 0.75% | |
| DEXCOM INC | 0.74% | |
| PENUMBRA INC | 0.70% | |
| INSMED INC | 0.68% | |
| Novartis AG | 0.65% | |
| INCYTE CORP | 0.61% | |
| MEDLINE INC-A | 0.61% | |
| WATERS CORP | 0.60% | |
| BLKR-LIQ T-INS | 0.52% | |
| PROTAGONIST THERAPEUTICS INC | 0.52% | |
| AGILENT TECHNOLOGIES INC | 0.50% | |
| PFIZER INC | 0.50% | |
| NUVALENT INC-A | 0.49% | |
| COGENT BIOSCIENCES INC | 0.48% | |
| GUARDANT HEALTH INC | 0.48% | |
| REVOLUTION MEDICINES INC | 0.47% | |
| MODERNA INC | 0.46% | |
| GALDERMA GROUP A | 0.44% | |
| CVS HEALTH CORP | 0.44% | |
| ELEVANCE HEALTH INC | 0.43% |
HRTS (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.02% | |
| Roche Holding AG | 5.47% | |
| JOHNSON&JOHNSON | 4.86% | |
| ASTRAZENECA PLC | 4.82% | |
| MERCK & CO | 4.24% | |
| THERMO FISHER SCIENTIFIC INC | 3.90% | |
| UNITEDHEALTH GRP | 3.85% | |
| GILEAD SCIENCES INC | 3.62% | |
| Novartis AG (Registered) | 3.62% | |
| ABBOTT LABS | 3.37% | |
| VERTEX PHARMACEUTICALS INC | 3.21% | |
| ABBVIE INC | 2.96% | |
| DANAHER CORP | 2.92% | |
| BOSTON SCIENTIFIC CORP | 2.47% | |
| MEDTRONIC PLC | 2.37% | |
| BRIDGEBIO PHARMA INC | 2.23% | |
| REVOLUTION MEDICINES INC | 2.22% | |
| BRISTOL-MYERS SQUIBB CO | 2.17% | |
| MCKESSON CORP | 2.16% | |
| NOVO NORDISK-B | 2.15% | |
| AMGEN INC | 2.10% | |
| CHUGAI PHARMA CO | 2.06% | |
| REGENERON PHARMACEUTICALS INC | 2.02% | |
| EDWARDS LIFESCIENCES CORP | 1.86% | |
| TEVA PHARMACEUTICAL IND ADR | 1.62% | |
| CYTOKINETICS INC | 1.48% | |
| INTUITIVE SURGICAL INC | 1.47% | |
| MASIMO CORP | 1.36% | |
| DEXCOM INC | 1.29% | |
| MADRIGAL PHARMACEUTICALS INC | 1.21% | |
| INSMED INC | 1.19% | |
| ALNYLAM PHARMACEUTICALS INC | 1.19% | |
| INSULET CORP | 1.04% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.03% | |
| VIKING THERAPEUTICS INC | 0.85% | |
| IONIS PHARMACEUTICALS INC | 0.83% | |
| SCHOLAR ROCK HOLDING CORP | 0.78% | |
| Ascendis Pharma A/S | 0.75% | |
| CRINETICS PHARMACEUTICALS INC | 0.64% | |
| FIRST AM-TR OB-X | 0.59% | |
| NEUROCRINE BIOSCIENCES INC | 0.57% | |
| ZEALAND PHARMA A | 0.56% | |
| GUBRA A/S | 0.51% | |
| INTELLIA THERAPEUTICS INC | 0.35% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.